easo update
Semaglutide vs Tirzepatide for GPs Skeptical
Slightly less than 1-in-10 primary-care clinicians are fully confident in the updated EASO recommendations for GLP-1 receptor agonists, and the choice between semaglutide and tirzepatide hinges on patient phenotype, efficacy evidence, and guideline hierarchy. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always